Effects of pecan nut consumption on the metabolism of adults with Obesity

Not Applicable

• Conditions: Obesity

• Registration Number: RBR-4nmdwr
• Lead Sponsor: Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-09-24
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Volunteers aged 20 to 59 years; body mass index (BMI) equal to or greater than 30 kg / m² due to excess body fat; who agreed to participate voluntarily in the study; and that they would be willing to follow the proposed recommendations.

Exclusion Criteria

Participants with: 1) psychiatric disorders, history of cancer, endocrine disorders (adrenal diseases, thyroid diseases, polycystic ovarian syndrome, diabetes mellitus and dyslipidemia in drug and non-drug treatment), spoliation status (fever, malabsorption syndrome, surgery), inflammatory, infectious, autoimmune, renal, cardiovascular, hepatic (cirrhosis, hepatitis, and hepatic insufficiency) diseases; 2) use of weight-loss, appetite-suppressing, immunosuppressive, anti-inflammatory, corticosteroid, antibiotic, hypolipidemic, antidiabetic, anticoagulant, antihypertensive, hormonal (except stable contraceptive use for at least 6 months); 3) frequent consumption of nuts, including peanuts and baru almonds (one or more times in the week); 4) allergy or food intolerance to any type of nuts (including peanuts or baru almonds); 5) use of dietary supplements; 6) alcoholics, smokers or drug abuse; 7) women in climacteric, pregnant and nursing mothers; 8) performing restrictive diet or dietary treatment.

Study & Design

• Study Type: Intervention
• Study Design: Not specified